Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Umbilical Vein Injection of 800µg Misoprostol Versus 400 µg Misoprostol in the Treatment of Retained Placenta: A Multicenter, Randomized Double Blind Controlled Trial

NCT02704780 is registered in ClinicalTrials.gov with Hawler Medical University as lead sponsor.

NCT NCT02704780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02704780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Umbilical Vein Injection of 800µg Misoprostol Versus 400 µg Misoprostol in the Treatment of Retained Placenta: A Multicenter, Randomized Double Blind Controlled Trial
Lead sponsor
Hawler Medical University
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2016
Completion date
February 14, 2019
Enrollment
509 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum haemorrhage, retained placenta